A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation.
about
The UCSC Genome Browser database: 2017 updateBedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research.Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.Quantifying survival in patients with Proteus syndrome.Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio.Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals.A primer to clinical genome sequencingMatchmaking facilitates the diagnosis of an autosomal-recessive mitochondrial disease caused by biallelic mutation of the tRNA isopentenyltransferase (TRIT1) gene.Genomic medicine for kidney disease.When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings.From public health genomics to precision public health: a 20-year journey.Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care.MECP2 variation in Rett syndrome - an overview of current coverage of genetic and phenotype data within existing databasesHarmonizing Outcomes for Genomic Medicine: Comparison of eMERGE Outcomes to ClinGen Outcome/Intervention PairsIdentification of Misclassified ClinVar Variants via Disease Population Prevalence
P2860
Q28584444-EAB5E17E-327F-4062-BC1B-11969D95BD25Q33906483-952B5600-4F02-4AF8-B2D5-4BF0AF9C1422Q38644627-4CD1B20C-2D75-48E2-A64E-F09CD81AECBCQ38702638-A369F7E5-8620-40BE-9FCB-A2A84CB1911DQ38822784-F460C601-3EFC-43A1-9E2E-5F5FDFA1BAA5Q38987441-764F5A39-5E3B-49A1-8A6B-59D551B96C51Q41639348-013EFB92-366E-41D5-8340-9F433C1D0126Q41920819-CB64C96D-C4D2-47B3-A717-FD94052FE828Q47200436-AAC756C0-944F-46C5-A17D-CF00A9707DC3Q47294616-4CECC55D-FC92-48D7-8CE2-C66863BED209Q47717402-9D87203C-3755-480C-901E-96D1C7074070Q49498072-F5AC3394-60AC-4497-A174-59FFDA7E25E1Q49841808-DE8B65E2-8923-4EFC-A8BD-3F352B0169E5Q49951884-1782AD82-E7B1-4300-9F07-D9E25B7F5772Q52312226-4C0764DF-B0D5-4C6C-830A-80CF46900207Q57306569-3C7EF585-51C4-4458-83F8-FA6392D5D60DQ57640462-96D734FD-EBBD-49ED-996B-9F0CF973A7A1
P2860
A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A standardized, evidence-based ...... ciated with genomic variation.
@en
A standardized, evidence-based ...... ciated with genomic variation.
@nl
type
label
A standardized, evidence-based ...... ciated with genomic variation.
@en
A standardized, evidence-based ...... ciated with genomic variation.
@nl
prefLabel
A standardized, evidence-based ...... ciated with genomic variation.
@en
A standardized, evidence-based ...... ciated with genomic variation.
@nl
P2093
P2860
P50
P356
P1433
P1476
A standardized, evidence-based ...... ociated with genomic variation
@en
P2093
Alan F Scott
Anne Slavotinek
Brian Jensen
Christa Lese Martin
Erin M Ramos
Laura Milko
Leslie G Biesecker
Meredith Weaver
Nara Sobreira
P2860
P2888
P304
P356
10.1038/GIM.2016.40
P407
P50
P577
2016-04-28T00:00:00Z